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Poxvirus genome uncoating is a two-step process.
First, cytoplasmic viral cores are activated and early
viral genes are expressed. Next, cores are disas-
sembled and the genomes released. This second
step depends on an early viral factor(s) that has
eluded identification for over 40 years. We used a
large-scale, high-throughput RNAi screen directed
against vaccinia virus (VACV) to identify the VACV
AAA+ ATPase D5 as the poxvirus uncoating factor.
We show that the ATPase activity of D5 is required
for uncoating. Superresolution microscopy suggests
that D5 acts directly at viral cores for genome
release. Thus, the putative helicase D5 is amultifunc-
tional protein required for genome uncoating and
replication. Additionally, in vivo delivery of anti-D5
siRNAs reduced virus production in a mouse model
of VACV infection. These results demonstrate the
use of virus-targeting RNAi libraries to investigate
viral gene function and suggest therapeutic avenues.
INTRODUCTION
In virus particles, the genome is often packaged inside a stable,
highly structured, proteinaceous core or capsid. It allows the
viral DNA or RNA to be highly condensed and provides protec-
tion during the extracellular phase of the replication cycle. The
structural design of a viral core must also include a built-in
capacity for disassembly, because after entry into a new host
cell, the genome is rapidly liberated in a process called
uncoating. This must occur at the right time and place inside
the host cell. Themechanisms of uncoating remain poorly under-
stood for most animal virus capsids, yet it is evident that all
viruses must undergo critical changes during entry that render
them uncoating competent. The changes are often triggered
by alterations in the milieu around the virus or by interactions
with receptors or other host factors. They involve proteolytic
cleavages, reduction or rearrangement of disulfide bonds, andCell Hostchanges in protein conformation (Suomalainen and Greber,
2013; Greber et al., 1994).
In this study, we focused on the genome uncoating of vaccinia
virus (VACV), a poxvirus closely related to the causative agent of
smallpox. The poxvirus replication cycle is exclusively cyto-
plasmic and begins with the delivery of a stable core, containing
the viral DNA genome, into the host cytosol. Upon delivery, cores
undergo activation and early genes are transcribed within the
intact viral core; mRNAs are exported and translated in the
cytosol, giving rise to a defined set of early proteins involved in
intermediate gene transcription, DNA replication, host interac-
tion, and immune modulation. Subsequent intermediate and
late gene expression occurs from virus genomes only after
DNA release and replication (Moss, 2007).
In classical poxvirus studies, uncoating was defined as the
step that rendered viral DNA sensitive to DNase digestion in
cell lysates (Joklik, 1964a). It was observed over 40 years ago
that expression of one or more early viral proteins was required
for this step (Joklik, 1964b; Prescott et al., 1971). The early viral
protein(s) involved in uncoating has, however, not been identified
to date.We recently demonstrated that VACV genome uncoating
is a multistep process in which host cell proteasome activity is
necessary but not sufficient (Mercer et al., 2012). Yet, the mech-
anism of uncoating remains elusive, and a detailed understand-
ing requires the identification of the poxvirus uncoating factor(s).
Here, we addressed the problem by silencing VACV early
genes using a high-throughput RNAi screen. Genome-wide
RNAi screens have been used in recent years to address the
role of host genes during virus infection (Kilcher and Mercer,
2014). By applying the same approach to viral genes, we could
unambiguously identify one early protein as the viral uncoating
factor. Consistent with its critical role in the VACV life cycle,
siRNA-mediated depletion of the uncoating factor in infected
mice reduced virus replication.
RESULTS
RNAi Screen Identifies 15 Uncoating Factor Candidates
To identify the VACV uncoating factor(s), we performed an auto-
mated high-throughput infection screen in HeLa cells with
siRNAs targeting early VACV mRNAs. The custom-made library
targeted 80 conserved viral proteins using three individual& Microbe 15, 103–112, January 15, 2014 ª2014 Elsevier Inc. 103
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Figure 1. Antiviral siRNA Screen Reveals 15 Uncoating-Factor Candidates
(A–D) An siRNA screen targeting early mRNAs of VACV was used to identify viral proteins required for uncoating, DNA replication, or intermediate gene
expression. Transfected HeLa cells were infected with VACV strains expressing EGFP from early or intermediate viral promoters (E EGFP and I EGFP,
respectively), and the fraction of infected cells was quantified. Workflow and screening strategy are shown (A and B) along with exemplary images of the
phenotypes after depletion of the viral DNA polymerase E9 (C). The I EGFP/E EGFP relative infection ratio of the final 15 candidate genes is shown in (D) with three
siRNAs/gene (grouped bars). The threshold at a ratio of 0.6 is indicated (red line). Scale bars represent 100 mm. Data are mean ±SEM (n = 3). HI indicates host
interaction; RISC indicates RNA-induced silencing complex. See also Figure S1 and Tables S1 and S2.
Cell Host & Microbe
AAA+ ATPase D5 Uncoats Vaccinia Virus GenomesiRNAs per gene (see Table S1 available online). The screening
strategy and workflow is outlined in Figures 1A and 1B (quality
control is shown in Figure S1).
As VACV intermediate, but not early, gene expression de-
pends on DNA release and replication, we reasoned that deple-104 Cell Host & Microbe 15, 103–112, January 15, 2014 ª2014 Elsevtion of the poxvirus genome uncoating factor should impair
intermediate, but not early, gene expression. The library was
screened in parallel using recombinant reporter viruses express-
ing enhanced green fluorescent protein (EGFP) under the control
of the early J2R promoter (VACV E EGFP; Stiefel et al., 2012) orier Inc.
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AAA+ ATPase D5 Uncoats Vaccinia Virus Genomethe intermediate G8R promoter (VACV I EGFP; all viruses used in
this study are compiled in Table S3). The fraction of cells under-
going viral gene expression upon siRNA-mediated depletion of
candidate proteins was quantified by automated fluorescence
microscopy and compared to control siRNA (relative infection).
Figure 1C exemplifies the expected phenotype in cells trans-
fected with an siRNA against the viral DNA polymerase E9
(siE9L): EGFP expression from the intermediate, but not the
early, gene promoter was abrogated.
As a readout, the ratios of relative I EGFP/E EGFP infection
were determined. This allowed us to identify viral genes involved
in the VACV life cycle between early and intermediate gene
expression (i.e., for genome uncoating, DNA replication, or inter-
mediate gene transcription). The I/E EGFP ratio excluded siRNAs
that affected both E and I EGFP expression in an unspecific
manner (off target). Fifteen candidates were identified with an
I/E EGFP ratio below 0.6 for 2–3/3 siRNAs (Figure 1D). Most
are required for DNA replication (six genes) or intermediate
gene transcription (eight genes), including the DNA polymerase
E9 and several RNA polymerase subunits. For full screening
results, see Figure S1 and Table S2.
Four Candidate Genes Are Required for the Assembly of
Prereplication Sites
We did not identify any factor lacking an assigned function and
suspected that one of the 15 candidates may have an additional
role in uncoating. Thus, we aimed at eliminating candidates that
were only required after uncoating (i.e., for DNA replication and
intermediate gene expression). We quantified ‘‘prereplication
sites’’—distinct cytoplasmic spots in which the DNA replication
machinery assembles on released incoming viral genomes
(Domi and Beaud, 2000; Rochester and Traktman, 1998; Tseng
et al., 1999;Welsch et al., 2003). These sites formwhen newDNA
synthesis is inhibited by cytosine arabinoside (AraC). As they can
be visualized microscopically by staining for the viral ssDNA-
binding protein I3, they have been used as an indirect measure
for genome release (Mercer et al., 2012).
The number of prereplication sites per infected cell was quan-
tified after candidate gene knockdown using one potent
nontoxic siRNA per gene (see Table S1 for selected siRNAs);
nontargeting siRNA served as control (ASN). On average, ten
I3-positive prereplication sites per cell were detected under the
experimental conditions (Figures 2A and 2B). I3 foci were virtu-
ally absent when viral protein expression was inhibited (ASN +
cycloheximide [CHX]) or when I3 was depleted by siRNA (Figures
2B and S2A). Of the 15 candidates, four showed more than 40%
reduction in the number of prereplication sites per cell and were
further pursued: the viral kinase B1, the primase/helicase D5, the
putative nuclease G5, and I3 itself (positive control) (Figures 2A,
2B, and S2A).
The Viral Primase/Helicase D5 Is Required for Core
Breakdown
After delivery into the cytoplasm, VACV cores are rapidly disas-
sembled. Using inhibitors of early gene expression (actinomycin
D [ActD] or CHX) or proteasomal activity (MG-132) to prevent
uncoating, we and others have shown that core disassembly
and genome uncoating are concomitant events (Joklik, 1964b;
Mercer et al., 2012; Sarov and Joklik, 1972). We assessed ifCell Hostknockdown of the remaining four candidates resulted in core
accumulation (Figures 2C and 2D). HeLa cells were transfected
with siRNAs against B1, D5, G5, I3, or A20 (control) and infected
for 3.5 hr using a recombinant virus with a fluorescent fusion pro-
tein in the core (VACV WR EGFP-A4; Schmidt et al., 2011).
Immunofluorescence (IF) staining of the viral membrane protein
L1 was used to distinguish free cytoplasmic cores from mature
virions (MVs). The number of bound or internalized MVs per
cell was similar under all conditions (Figure 2D). As expected,
few free cores were observed under control conditions (ASN),
whereas the number of cores increased about 10-fold when
uncoating was blocked (CHX). While depletion of B1, G5, I3,
and A20 had no effect on the number of free cores, depletion
of D5 resulted in core accumulation similar to CHX treatment
(Figures 2C and 2D).
D5 was the only candidate protein whose depletion prevented
the formation of DNA prereplication sites and the loss of viral
cores, strongly suggesting that it is involved in viral uncoating
and/or core degradation. To test the role of D5 using an indepen-
dent approach, we employed the temperature sensitive (ts)
VACV strain Cts24 (Condit and Motyczka, 1981), which encodes
a ts mutant of D5 that is thermolabile at nonpermissive temper-
ature (40C) (Boyle et al., 2007; Evans and Traktman, 1992). We
analyzed the formation of prereplication sites (Figure 2E) and
constructed Cts24 EGFP-A4 to address the core stability by IF,
as described above (Figure 2F). At permissive temperature
(31C), the number of prereplication sites and cores in WR WT
and Cts24-infected cells was comparable. At nonpermissive
temperature, prereplication sites did not form, and cores accu-
mulated in cells infected with Cts24 viruses (Figures 2E, 2F,
and S2B). As Cts24 allows for efficient D5-depletion over an
extended period of time, we used this virus in time course exper-
iments to assesswhether D5 depletion leads to a block or a delay
of core breakdown. While cores were completely degraded
within 4 hr at 31C, they remained stable at nonpermissive tem-
perature for at least 8 hr, proving that loss of functional D5
causes a profound block of core degradation (Figure 2G).
D5 Is Required for the Release of the Viral Genome from
Incoming Cores
To probe the release of VACV genomes, we established a flow-
cytometry- and a microscopy-based uncoating assay (work-
flows depicted in Figures 2H and 2I). The flow-cytometry-based
uncoating assay quantifies the accessibility of viral genomes to
cytosolic T7 RNA polymerase using a recombinant vaccinia virus
encoding EGFP under the control of the T7 promoter (WR T7
EGFP). To test specificity, HeLa cells encoding T7 RNA polymer-
ase under the control of a doxycycline-inducible promoter (HeLa
T7i) were infected with WR T7 EGFP in the absence or presence
of doxycycline. EGFP was expressed only when T7 RNA poly-
merase was present (Figure 2J; +D). The proteasome inhibitor
MG-132—which blocks VACV genome uncoating—efficiently
prevented EGFP expression (Figures 2J and S2C). Collectively,
these results indicated that the viral genome within the core
was not accessible to T7 RNA polymerase and that EGFP
expression only occurred from released genomes.
Using this assay, the 15 initial candidate genes were reeval-
uated. Depletion of most factors showed only modest effects
on EGFP expression and, thus, on uncoating. Interestingly, two& Microbe 15, 103–112, January 15, 2014 ª2014 Elsevier Inc. 105
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B1 increased EGFP expression two-fold, and D5 siRNA reduced
genome release by more than 50% (Figures 2K and S2D). Thus,
the role of D5 in genome uncoating was confirmed.
To directly visualize genome release, we developed a micro-
scopy-based uncoating assay that relies on incorporation of
5-ethynyl-20-deoxyuridine (EdU) into the viral DNA. VACV WR
mCherry-A4 (red-fluorescent core) was produced in the pres-
ence of EdU (WR mCherry-A4 EdU-DNA) (Wang et al., 2013).
After infection and fixation, EdU-containing viral genomes were
labeled by coupling fluorescent azides to EdU. This allowed for
simultaneous detection of viral DNA and cores and, thus, differ-
entiation between released and nonreleased genomes. HeLa
cells were infected with WR mCherry-A4 EdU-DNA for 4 hr in
the presence of D5 siRNA. For these assays, CHX and MG-
132 served as positive controls, and ASN and A20 siRNAs
served as negative controls. Confocal microscopy images
were acquired (Figure 2L), and genomes classified as uncoated
or core associated. As expected, both CHX and MG-132
blocked genome release, whereas ASN and A20 siRNAs had
no effect (Figure 2M). In confirmation of its role in genome
uncoating, depletion of D5 prevented genome release as effi-
ciently as MG-132 treatment (Figures 2L and 2M).
To compare the genome-release assays reported here to
established DNase protection assays (Joklik, 1964a), we pro-
duced 3H-thymidine-labeled Cts24 MVs and quantified sensi-
tivity of viral genomes to DNase I digest after infection of
BSC-40 cells at permissive (31C) and nonpermissive (40C)
temperatures. At 31C, about 60% of the genomic DNA from
cell lysates was sensitive to DNase I digestion. Consistent with
our uncoating assays, VACV DNA remained largely protected
from DNase I digestion in lysates from cells infected at 40C or
in the presence of CHX (Figure S2E).
The data obtained from these three independent uncoating
assays demonstrate that D5 is required for genome release.
Thus, in line with its requirement for prereplication site formation
and core disassembly, D5 is the only viral factor from the 80 orig-
inally screened that fulfilled all of the requirements of a bona fide
VACV genome uncoating factor.
SilentMutations of D5RRender Uncoating Insensitive to
siD5R
To monitor D5 expression, we generated recombinant viruses
expressing N- or C-terminally HA-tagged D5 from its endoge-
nous locus (WR HA-D5 and WR D5-HA). To test the specificity
of siD5R, we generated virus strains encoding siRNA-insensitive
HA-D5 or D5-HA (WR HA-D5 ins and WR D5-HA ins; Figure S2I).
The I EGFP reporter cassette was introduced into the nonessen-
tial tk locus of the aforementioned virus strains to quantifyFigure 2. D5 Is the VACV Genome-Uncoating Factor
(A–L) DNA prereplication sites (A, B, and E) and accumulated viral cores (C, D, F, an
D–G) in VACV-infected cells either transfected with the indicated siRNA and/or infe
(E–G). T7 RNA-polymerase-driven EGFP expression from released genomes was
which T7 RNA polymerase was expressed (+D) or not (D). Released viral geno
were visualized (L) and quantified (M) as EdU-DNA-positive spots negative for core
Scale bars represent 15 mm.Data aremean ±SEM (n = 3). Arrowheads indicate pre
respectively. E term indicates early transcription terminator sequence; EMCV IR
indicates T7 RNA polymerase transcription terminator sequence. See also Figur
Cell Hostinfection. None of the viruses had plaque-formation defects,
suggesting that the tags, silent mutations, and insertions did
not compromise virus fitness (data not shown).
These viruses allowed us to assess intermediate gene expres-
sion and simultaneously monitor HA-tagged D5 by IF staining
and flow cytometry. We confirmed that D5 knockdown almost
completely blocked intermediate gene expression, which was
rescued when the siRNA-insensitive variant of D5R was ex-
pressed (Figures S2F and S2G). Moreover, we could validate
the knockdown of D5 by siD5R and verify that the introduced
silent mutations rendered D5 expression insensitive to siD5R
(Figures S2F and S2G).When the T7 EGFP cassette was inserted
into WR D5-HA and WR D5-HA ins viruses to perform our T7
RNA-polymerase-based uncoating assay, uncoating of WR
D5-HA T7 EGFP genomes was reduced by siD5R, while WR
D5-HA ins T7 EGFP remained siRNA insensitive (Figures S2H
and S2I). These results prove that depletion of D5 alone was
responsible for the phenotypes observed in the presence of
siD5R.
The AAA+ ATPase Domain of D5 Is Required for
Uncoating
D5 is a well-established component of the VACVDNA replication
machinery and contains a confirmed N-terminal primase and a
predicted C-terminal SFIII helicase (AAA+ ATPase) domain,
both of which are essential for DNA replication (Boyle et al.,
2007; De Silva et al., 2007; Evans et al., 1995). As D5 is essential,
it was impossible to disrupt the primase or ATPase (putative heli-
case) activity in the endogenous gene. Thus, to address the
requirement of the two catalytic domains for intermediate gene
expression and uncoating, we synthesized a codon-optimized,
siRNA-insensitive version of D5 carrying an N-terminal FLAG
tag (FLAG-D5co) and introduced point mutations disrupting the
primase (D170A) or ATPase (N605D) activity (Boyle et al., 2007;
De Silva et al., 2007). In combination with the I EGFP cassette,
these FLAG-D5 variants were introduced into the VACV genome
as an additional copy using WR HA-D5 as the parental strain
(Figure 3A). Upon infection with these recombinant virus strains,
FLAG-D5 variants localized like HA-D5, were expressed to com-
parable amounts and were insensitive to D5 siRNA (Figures S3A
and S3B). To assess the requirement of D5 primase and ATPase
domains for intermediate gene expression, endogenous HA-
D5 was depleted by siRNA, and I EGFP expression was
quantified. While FLAG-D5 could readily substitute for loss of
HA-D5, both primase and ATPase activities were required for in-
termediate gene expression (Figures 3B and 3C). The mutants
were then assessed for their ability to support prereplication
site formation. Interestingly, disruption of the D5 ATPase domain
abrogated prereplication site formation to background levels,dG)were visualized using confocal microscopy (A andC) and quantified (B and
cted withWRWT (A and B), WR EGFP-A4 (C andD), or with the indicated strain
measured by flow cytometry in drug- (J) and siRNA-treated (K) HeLa T7i cells, in
mes in siRNA-transfected HeLa cells infected with WR mCherry-A4 EdU-DNA
fluorescence. Details of the genome release assays are presented in (H) and (I).
replication sites (A),MVs (closed) or cores (open) (C), and released genomes (L),
ES indicates encephalomyocarditis virus internal ribosomal entry site; T7 term
e S2.
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These results indicate that the uncoating and DNA replication
functions of D5 have different enzymatic requirements.
D5 Localizes to Distinct Subdomains of Incoming Viral
Cores
The enzymatic activities of D5 have been studied in vitro, and a
number of findings suggest that D5 is associated with the viral
DNA replication complex during infection. These include the
requirement of D5 for DNA replication, its function as a primase,
and the predicted helicase activity, as well as a recent low-reso-
lution structure of the DNA replication machinery (Boyle et al.,
2007; De Silva et al., 2007; Evans et al., 1995; Iyer et al., 2001;
Se`le et al., 2013). However, the localization of D5 in infected cells
has never been investigated. HeLa cells were infected with WR
HA-D5 for 4 hr. Consistent with an essential role during DNA
replication, HA-D5 localized to virus factories in untreated cells
and I3-positive prereplication sites in the presence of AraC
(Figure 3E).
We hypothesized that D5 might act directly on released cyto-
plasmic viral cores to facilitate genome uncoating. To visualize
VACV cores and D5 simultaneously, we generated a recombi-
nant virus in which both HA-D5 and EGFP-A4 were expressed
from their endogenous loci under the control of their natural pro-
moters (WRHA-D5 EGFP-A4; Figure S3D). Using this virus, cyto-
solic cores were accumulated in the absence of early gene
expression (CHX). After 100 min, when the majority of cores
had reached the cytosol, cells were shifted into medium contain-
ing AraC and MG-132, allowing for the expression of early genes
while preventing uncoating, core disassembly, and DNA replica-
tion. The localization of HA-D5 was then analyzed over time. We
found that HA-D5 colocalized with free cytoplasmic cores in
90% of the cells 4 hr post-CHX washout (Figures 3F and 3G).
At the 4 hr time point, we also found D5 spots close to, but not
colocalizing with, cores in about 20%of the cells (Figure 3F, right
image). These spots likely represent prereplication sites contain-
ing released DNA, due to an incomplete block of uncoating in the
presence of MG-132 at high multiplicities of infection.
The association of D5 with incoming cores in the absence of
proteasome activity further confirms a role for D5 prior to DNA
replication. To exclude the possibility that viral DNA replication
proteins generally associate with incoming cores, we generated
WR HA-I3 EGFP-A4 (Figures S3C and S3D). When subjected to
the same assay, we found that HA-I3 did not colocalize to
incoming cores at any time point assayed (Figure 3H), while
the levels of HA-I3 and HA-D5 in prereplication sites were com-Figure 3. D5 Localizes to Incoming Cores and Requires ATPase Activi
(A–E) To address the requirement of the primase and AAA+ ATPase domains of D5
the endogenous locus and an additional codon-optimized version of the D5R
nonessential tk locus of VACV. FLAG-D5co encodes either the WT protein or al
(N605D) domain (A). Intermediate gene expression (B and C) and viral prereplicati
with the indicated viruses. To test the localization of HA-D5 with respect to virus
cells were infected with WR HA-D5 for 4 hr in the absence or presence of AraC to
staining with anti-HA, phalloidin, and DRAQ5 (DNA) or anti-I3, where indicated (E
(F–H) To visualize cores and HA-D5/HA-I3 simultaneously, HeLa cells were infecte
of CHX and chased into MG-132 + AraC for 4 hr. The percentage of cells in which
over time (G and H). Representative images of both phenotypes observed 4 hr p
are shown (Z projection) and compared to conventional fluorescence microscopy
2 mm (I). See also Figure S3.
Cell Hostparable. We then employed 3D structured illumination micro-
scopy (SIM) to address the localization of D5 on cores with
higher resolution (Figure 3I). In most cytosolic particles, D5 local-
ized to the long sides of the core, forming two distinct foci.
Taken together, our data suggested that D5 acts on distinct,
possibly lateral, subdomains of viral cores before other compo-
nents of the replication machinery have access to the DNA. It is
tempting to speculate that these structures mark potential exit
portals for the viral DNA.
In Vivo Delivery of Antiviral siRNAs Reduces Virus
Production in a Mouse Model of VACV Infection
Our screen provides infection data on 240 individual siRNAs that
can potentially be used to study specific functions of VACV early
proteins in cell culture. From a more applied point of view, we
have identified a number of siRNAs that efficiently block VACV
infection at low concentrations with little associated cell toxicity
(Figure S1 and Table S2). The most potent siRNAs targeted the
uncoating and DNA replication factor D5 (D5R oligo number 2)
and the viral DNA polymerase E9 (E9L oligo number 1). Both
siD5R and siE9L completely abolished intermediate without
strongly affecting early gene expression (Figure 4A).
To test the antiviral potential of these siRNAs in an infected
organism, we assessed virus production after siRNA administra-
tion in a mouse model of VACV infection. We found that delivery
of siD5R and siE9L, but not control, siRNA significantly reduced
virus production in the lung, as well as replication in liver and
spleen (Figure 4B). These data indicate that the viral uncoating
factor D5, and potentially other essential early genes, is a prom-
ising antiviral target and highlight the therapeutic potential of
RNAi-based antiviral treatment.
DISCUSSION
The proteinaceous structure that encapsidates the poxvirus
genome is not inherently unstable once it is released into the
host cell cytosol (Pedersen et al., 2000). Instead, poxviruses
undergo a stepwise uncoating process that involves core activa-
tion and genome release. While core activation occurs immedi-
ately after membrane fusion (Schmidt et al., 2013), genome
release requires proteasome activity and the expression of early
viral genes. Here, we demonstrate that the VACV AAA+ ATPase
D5 is a multifunctional protein required for genome uncoating
and DNA replication. Evolutionarily, D5 is conserved, encoded
by all poxviruses, and identified as one of the proteins shared
by all nucleo-cytoplasmic large DNA viruses (Iyer et al., 2006).ty for Uncoating
for DNA replication and uncoating, we constructed viruses encoding HA-D5 in
gene (FLAG-D5co), in combination with an I EGFP reporter cassette in the
ternatively D5 bearing mutations inactivating the primase (D170A) or ATPase
on sites (D) were quantified in cells transfected with ASN or siD5R and infected
factories (positive for viral DNA) and prereplication sites (positive for I3), HeLa
accumulate virus factories and prereplication sites, respectively, followed by
).
d withWRHA-D5 EGFP-A4 (F andG) orWRHA-I3 EGFP-A4 (H) in the presence
HA-D5/HA-I3 colocalized with cores and/or prereplication sites was quantified
ost-CHX washout are shown in (F). SIM images of HA-D5 on cytosolic cores
in (I). All data are mean ±SEM (n = 3). Scale bars represent 15 mm (E and F) or
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Figure 4. Antiviral siRNAs Can Curtail VACV Replication In Vivo
(A–D) Early and intermediate gene expression in VACV-infected HeLa cells treated with the indicated siRNAs was quantified along with the number of cells (A).
C57BL/6 mice were treated with the indicated siRNAs and infected 8 hr postdelivery. Three days later, lungs (B), livers (C), and spleens (D) were collected, and
virus titers determined. Data are mean ±SEM. p values are indicated (*p < 0.05; **p < 0.01, unpaired t test).
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tains an N-terminal primase domain, as well as a C-terminal
AAA+ ATPase domain classified as a putative SFIII helicase
(Iyer et al., 2006). Primase and NTPase activity of D5 have
been verified in vitro, and experiments with temperature-sensi-
tive mutants of D5 show that it plays a direct role in DNA replica-
tion (Boyle et al., 2007; De Silva et al., 2007; Evans et al., 1995).
Our mutagenesis experiments reveal that the uncoating function
of D5 is independent of its primase activity. Therefore, the two
functions of D5 during the viral life cycle can be mechanistically
separated. That D5 is recruited to incoming cores in the absence
of proteasomal activity suggests that it acts directly on virus
cores to release the genome.
D5 could facilitate uncoating in several different ways:
Genome release may involve the complete disruption of viral
cores (e.g., by the global degradation of core structural proteins
or the destruction/release of critical core stabilizing compo-
nents). In support of this, inhibitors of uncoating lead to the
accumulation of cores (Mercer et al., 2012; Pedersen et al.,
2000), and broken VACV cores were observed in infected cells
by electron microscopy (Cyrklaff et al., 2007; Pedersen et al.,
2000). As a AAA+ ATPase that converts the energy released
by NTP hydrolysis into conformational changes in the hexame-
ric ring, D5 may be suitable to actively contribute to core
disassembly.
Alternatively, it is conceivable that genome uncoating in-
volves the opening of a channel or defined exit site in the
core wall, as observed in the case of herpesviruses (Brown
and Newcomb, 2011) and certain bacteriophages. In support
of an exit portal, D5 localizes to distinct core domains, as re-
vealed by our SIM data. Mechanistically, T7 and N4 phages
use the enzymatic activity of their RNA polymerases to pull
the genome into the cell (Zavriev and Shemyakin, 1982; Choi
et al., 2008). It is possible that, in the case of VACV, genome
release is intimately linked to the putative helicase activity of
D5, which may lead to the release of single-stranded DNA
(ssDNA). In fact, released genomes in prereplication sites can
be stained with antibodies directed against the viral ssDNA
binding protein I3 (Rochester and Traktman, 1998; Tseng
et al., 1999), even in the absence of ongoing DNA replication
(AraC). Releasing ssDNA would, in theory, allow the virus to
avoid recognition by double-stranded DNA receptors that could
trigger the intrinsic immune response.
Taken together, results in this and previous studies suggest
that cores released into the cytosol by fusion first undergo acti-110 Cell Host & Microbe 15, 103–112, January 15, 2014 ª2014 Elsevvation. This involves morphological changes, as well as the
reduction of viral disulfide bonds (Cyrklaff et al., 2007; Dales,
1963; Locker and Griffiths, 1999; Schmidt et al., 2012, 2013).
Transcription within activated cores allows the expression of
early proteins, such as D5. The activity of both host cell protea-
somes and D5 subsequently permits the genuine uncoating
step, the release of the viral genome. Interestingly, recruitment
of D5 to cores was only observed in the presence of the protea-
some inhibitor MG-132, indicating that the presence of D5 on the
core is transient and perhaps reversed by proteasomes. It
remains to be determined how these complexes cooperate to
facilitate uncoating and whether additional cellular factors are
involved.
Our study describes a comprehensive siRNA screen targeting
viral genes. A number of advantages make antiviral siRNA
screens an attractive strategy to identify viral genes required
for specific steps in the life cycle of other complex DNA viruses,
such as herpesviruses and NCLDVs: as no cellular mRNAs are
targeted, the siRNAs exhibit relatively low cell toxicity and
circumvent compensatory mechanisms often induced in cells
upon depletion of critical cell factors. Since the siRNAs are
administered before infection and production of early genes,
depletion efficiency is high and independent of protein stability.
As shown here in an in vivo mouse model of VACV infection,
such screens are likely to reveal sensitive viral target genes
and may lead to the identification of potent antiviral siRNAs.
We envision that similar screens may be used to systematically
probe the function of viral genes in other complex DNA viruses
and are confident that analogous approaches will prove benefi-
cial for both basic and applied virus research.
EXPERIMENTAL PROCEDURES
Antiviral siRNA Screen
Antiviral siRNA screens were performed in HeLa ATCC cells transfected
with siRNAs against 80 conserved early genes of VACV WR (20 nM, three
oligos/gene). Cells were infected with WR E EGFP or WR I EGFP 48 hr
posttransfection, fixed 7 hr postinfection, and stained with Hoechst and, in
case of WR E EGFP, with anti-EGFP antibodies. Images were acquired with
aMolecular Devices screeningmicroscope, and infection was quantified using
a custom-written Matlab program. See also Supplemental Experimental
Procedures.
Prereplication Site Formation, Core Accumulation, and Uncoating
Assays
To quantify prereplication sites, HeLa cells were infected in the presence of
AraC for 4–5.5 hr and stained with anti-I3 antibodies. To measure releasedier Inc.
Cell Host & Microbe
AAA+ ATPase D5 Uncoats Vaccinia Virus Genomecores, cells were infected with WR EGFP-A4 in the presence of AraC for 4 hr
and stained with anti-L1 (7D11) antibody to distinguish free cores from L1-
postive MVs.
To detect released genomes, WR mCherry-A4 EdU DNA was used to infect
cells in the presence of AraC for 4 hr, and EdU-containing genomes were
labeled with AF 488 azide. Prereplication sites, fluorescent cores and MVs,
and released viral genomes were quantified using the spot-detection function
of Imaris. To measure the accessibility of viral genomes to cytosolic enzymes,
HeLa cells inducibly expressing T7 RNA polymerase were infected withWR T7
EGFP in the presence of AraC. Cells were harvested 6 hr postinfection, and
EGFP expression was analyzed by flow cytometry. See Supplemental Exper-
imental Procedures for details.
In Vivo Delivery of Antiviral siRNAs
For delivery, 60 mg siRNA was complexed with in vivo jetPEI reagent
and injected into the tail vein of C57BL/6 mice. Eight hours posttransfec-
tion, mice were infected intratracheally with 5 3 106 plaque-forming units
WR WT. Virus titers in lungs, spleen, and liver were quantified 3 days
postinfection.
Cell lines, viruses, used reagents, and detailed methods are described in the
Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.chom.2013.12.008.
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